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Abstract
Background: The isolation of Propionibacterium acnes in blood cultures is often considered a contaminant. On rare
occasions, P. acnes can cause severe infections, including endocarditis and intravascular prosthesis-associated
infections. To evaluate the discrimination between a contaminant and a clinically relevant infection we used an
Ouchterlony test system to quantify the antibody response to P. acnes in a patient with a proven P. acnes
endocarditis.
Case presentation: We report on a 64-year-old Caucasian man who developed P. acnes endocarditis four years
following a composite valve-graft conduit replacement of the aortic root. Bacterial growth in blood cultures was
detected after an incubation period of 6 days. However, the antibody titer to P. acnes was 1:8 at the time of
diagnosis and declined slowly thereafter over 2½ years. The patient’s response to the antibiotic treatment was
excellent, and no surgical re-intervention was necessary.
Conclusion: The working hypothesis of infective endocarditis can be substantiated by serologic testing, which, if
positive, provides one additional minor criterion. Moreover, quantification of the antibody response to P. acnes,
though not specific, may assist in the differentiation between contaminants and an infection. This quantification
may have implications for the patient management, e.g. indication for and choice of the antibiotic therapy.
Keywords: Infective endocarditis, Prosthetic heart valve, Propionibacterium acnes, Serologic tests, Bacteremia,
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Background
Propionibacterium acnes is often considered a contamin-
ant when it grows in blood culture, akin to the growth
of coagulase-negative staphylococci, Bacillus sp., and
Corynebacterium sp. In a series of 522 patients with P.
acnes bacteremia, only 18 (3.5 %) were considered to
have a clinically significant bacteremia [1]. Diagnosis of
the latter required at least two sets of blood cultures
showing growth of P. acnes, and the patients had to have
a systemic inflammatory response syndrome [1]. In
equivocal cases, the availability of a serologic test for P.
acnes would assist in the differentiation between true in-
fection and contaminant bacterial growth. Moreover, the
slow growth of P. acnes in blood cultures requires pro-
longed incubation periods of up to two weeks [2]. In pa-
tients with suspected infective endocarditis, antibiotic
therapy often cannot be withheld for such a long dur-
ation. A higher diagnostic precision is desired in such
circumstances, and a positive serologic test for P. acnes
would confirm the diagnosis. Furthermore, the concen-
tration time course of the antibody titers can show a de-
cline in case of the elimination of P. acnes, or a late rise
indicating a relapse. Antibodies against P. acnes were
characterized using enzyme-linked immunosorbent as-
says (ELISAs) in patients with acne vulgaris [3] and in
patients with prostatitis and benign prostatic hyperplasia
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[4]. To our knowledge, serologic testing in patients with
suspected P. acnes endocarditis has not been reported
before. Thus, we describe a concentration time graph of
the antibody titer to P. acnes in a patient with proven in-
fective endocarditis. The potential clinical application of
serologic testing is discussed, and specific features of P.
acnes endocarditis, especially regarding its sometimes
difficult diagnosis, are outlined.
Case presentation
A 64-year-old Caucasian man had severe regurgitation
of the tricuspid aortic valve due to an aneurysm of the
ascending aorta, which involved the sinus of Valsalva.
Composite valve-graft conduit replacement of the aortic
root was performed 4 years ago. The patient suffered a
transient ischemic attack with a thrombotic occlusion of
a branch of the left middle cerebral artery 18 months
postoperatively, most likely due to subtherapeutic oral
anticoagulation (international normalized ratio [INR]
1.8). Transesophageal echocardiography (TEE) did not
show vegetations on the mechanical aortic valve and the
concentration of C-reactive protein was 1 mg/L (normal
value <5). Aspirin was then added to the vitamin K an-
tagonist phenprocoumon, and the patient successfully
self-monitored his INR values with a target range of
2.0–3.0. He did not use skin disinfectants, and he had
no acne.
A wasp sting to his upper lip was managed conserva-
tively one month prior to hospitalization, and subdued
sounds of his mechanical aortic valve were noticed by
the patient. No dental procedures were performed in the
six months prior to the sting. He became febrile up to
38 °C, had night sweats and felt ill. Upon admission, the
patient was in good general condition. His body
temperature was 37.3 °C; his blood pressure was 137/
94 mmHg; and his pulse rate was 79 bpm. There was a
1/6 systolic murmur and a metallic hue to the second
heart sound. There were no peripheral emboli in the
skin. The spleen was not enlarged. Laboratory results
showed an elevated concentration of C-reactive protein
(73 mg/L, Fig. 1) and a normal leukocyte count
(7.3×109/L [normal values 4.0–9.8]). The kidney function
(creatinine 90 μmol/L [62–110]) and the liver function
tests (aspartate transaminase [AST] 29 U/L [<38]) were
normal. The INR value was 2.4, consistent with thera-
peutic anticoagulation with phenprocoumon. The lactic
dehydrogenase was slightly elevated (655 U/L [<248]).
An infective endocarditis was suspected clinically, and
TEE was performed. Vegetations on the mechanical
bileaflet aortic valve were seen (Fig. 2), but there was no
perivalvular abscess formation. Ten blood cultures (Bac-
tecTM 9050, Becton Dickinson, Franklin Lakes, NJ) were
inoculated with 10 ml blood samples, five cultured
under aerobic and five under anaerobic conditions. All
blood cultures were obtained before starting the anti-
biotic therapy. Initially, no bacterial growth was ob-
served. Broad range polymerase chain reaction (PCR)
using 16S rDNA primers failed to identify bacteria in
blood samples. One anaerobic blood-culture showed
growth of a Gram-positive rod after 6 days, which was
sent to the reference laboratory for further testing. The
identification of P. acnes was performed according to
standard procedures with conventional tests. The Gram-
positive rods were catalase positive, showed a positive
Fig. 1 Concentration time graph of the C-reactive protein (open
circles, solid line) and the anti - P. acnes antibody titer (filled triangles,
dashed line). The latter was measured using the Ouchterlony
immuno-diffusion test. The antibiotic therapy is shown in the
horizontal bars below the graph (V. = Vancomycin, Genta. =
Gentamicin, Cef. = Ceftriaxone, Levof. = Levofloxacin)
Fig. 2 Photograph obtained during transesophageal echocardiography
(long axis view of the left ventricular outflow tract). Two vegetations (*)
are visible on the mechanical bileaflet aortic valve, protruding into the
left ventricular outflow tract in diastole. Ao = aorta, LA = left atrium,
LV = left ventricle
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CAMP reaction, reduced nitrate and produced indole,
but were lipase and lecithinase negative. Utilizing gas-
liquid chromatography, the production of propionic acid
from the glucose broth was detected. In four of 5 anaer-
obic blood cultures bacteria grew within 12 days, and
biochemical analysis again identified P. acnes; all aerobic
blood cultures remained sterile. Furthermore, the anti-
body response to this bacterium was quantified (Fig. 1).
According to the modified Duke criteria, a definitive
diagnosis of infective endocarditis was confirmed [5].
The initial antibiotic treatment included vancomycin
and gentamicin i.v. plus rifampicin p.o. After the identi-
fication of the P. acnes, vancomycin was stopped and
ceftriaxone was started. The intravenous therapy was
stopped after four weeks, and levofloxacine plus rifampi-
cin were prescribed for an additional four weeks of oral
antibiotic therapy. No bacteria grew in the blood cul-
tures following the completion of the antibiotic therapy.
A follow-up TEE showed no vegetations on the mechan-
ical aortic valve, and the patient continues to be well. He
consistently uses skin disinfectants prior to obtaining a
blood specimen for his INR measurements.
Sera drawn at different time points were tested for
antibodies against P. acnes by the Ouchterlony assay [6]
in the following 2½ years. For the antigen preparation of
the P. acnes strain (ATCC 6916, Manassas, VA) colonies
of 20 sheep blood agar plates were suspended in a tube
with 10 ml of phosphate buffered saline (pH 7.2) and
sonicated in a cup horn sonifier (60 W, Branson Sonic
Power Co., Danbury, CT) 8 times for one minute. The
tube was centrifuged at 2000xg for 10 min following
overnight storage at 4 °C. Aliquots of the supernatant,
each containing100 μL, were stored at −80 °C. The pa-
tient’s sera were tested against this antigen with the
Ouchterlony test [7]. The highest dilution of the serum
that still precipitated the P. acnes antigen in the Ouch-
terlony test system (ID Plates Cleargel, IMMY, Norman,
OK) represented the titer of this serum. The titers de-
creased during the following 2½ years indicating the
clearing of the bacteria without relapse (Fig. 1).
Discussion
Propionibacterium spp. are Gram-positive, slow-growing
anaerobic, non-spore-forming rods. They are part of the
normal flora of the skin, nasopharynx, oral cavity, and
genitourinary tract. Generally thought to be nonpatho-
genic in humans, they can cause infective endocarditis,
especially in carriers of mechanical heart valves and
pacemakers or implantable cardioverter defibrillators
(ICDs) [8]. This may be due to their ability to adhere to
foreign body surfaces and produce a biofilm. In a series
of 58 patients with infective endocarditis due to Propi-
onibacterium spp. published in 2009, prosthetic valve
endocarditis occurred in 67 % of the patients and was
the most common presentation of Propionibacterium
spp. infection. In addition to antimicrobial treatment,
81 % of the patient underwent cardiac surgery (due to
the propensity of the organism to form an abscess [9]),
and the overall mortality rate was 16 %[8]. The patient
described above was cured with antibiotic therapy alone.
Most of the infections of mechanical heart valves occur
at the time of surgery. With high inocula, a short incu-
bation period is expected. However, P. acnes may reside
intracellularly in macrophages and remain there dor-
mant for years [10]. In our patient, the infection may
also have occurred during the frequent skin punctures
necessary for the determination of the level of anticoa-
gulation [11]. Propionibacterium endocarditis may be
difficult to diagnose. The median incubation period re-
quired for blood cultures to become positive is 7 days
(range 5–14 days) [2]. Therefore, a prolonged incubation
period of two weeks is proposed in cases of suspected
infection with Propionibacterium spp. Additional diag-
nostic methods are often necessary. PCR to detect 16S
rDNA in blood is used in cases of blood culture-
negative infective endocarditis. However, its sensitivity is
lower than that of blood culture methods, and blood
specimens need to be pretreated to remove background
bacterial DNA contamination [12]. Gas-liquid chromato-
graphic examination of subcultured bacterial colonies
may assist in the detection of anaerobic bacteria [13]. In
blood culture-negative infective endocarditis, which oc-
curs in 2.5–31 % of all cases of infective endocarditis,
serologic techniques may be useful [14], and are estab-
lished to diagnose infections including Brucella spp.,
Coxiella burnetii [5], Bartonella spp., Mycoplasma spp.,
and Legionella spp.[15]. In the patient described above,
an antibody response to P. acnes was quantified (Fig. 1),
showing a titer of 1:8 at the time of diagnosis and a
gradual decline thereafter. Therefore, this antibody could
potentially facilitate the early diagnosis of infective endo-
carditis due to P. acnes. When uncertainty exists regard-
ing whether the growth of P. acnes in blood cultures is a
contaminant, as occurs in > 95 % of cases [1], or whether
it has a true pathogenetic role, a detectable antibody
titer would support the latter. However, increased anti-
body titers against P. acnes have been reported in dis-
eases such as acne vulgaris [16] or benign prostatic
hyperplasia [4], lowering their specificity. In patients
with acne a time course of the serology can detect a ris-
ing antibody titer suggesting P. acnes infection.
Treatment of P. acnes infective endocarditis primarily
consists of a β-lactam antibiotic, often combined with an
aminoglycoside [8], even though P. acnes is frequently
resistant to the latter [17]. Oral rifampicin must be
added because of its ability to penetrate the bacterial
biofilm [8] and may be combined with a chinolone anti-
biotic [18]. In vitro data suggest that the combination of
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daptomycin with rifampicin is highly active against P.
acnes biofilms [19]. Long-term antibiotic therapy is re-
quired for the successful treatment of infectious endo-
carditis due to P. acnes. The treatment effect is mirrored
by the decreasing antibody titer.
Conclusions
1. In patients with suspected P. acnes infective
endocarditis, a high antibody titer to the bacterium
is useful diagnostic adjunct. According to the
modified Duke criteria, serological evidence of active
infection represents a minor criterion for the
diagnosis of infective endocarditis [5].
2. Serologic testing may be useful in cases of P. acnes
bacteremia to differentiate between blood culture
contamination and a clinically relevant infection.
3. The Ouchterlony test used in the present case
report allows the analysis of the antibody titer to P.
acnes over time. Therefore, it may be useful even in
acne patients, even though the specificity will be
lower. Validation in a larger clinical cohort including
blood donors and patients with acne as controls is
important.
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